↓ Skip to main content

Contralateral breast cancer risk in BRCA1/2-positive families needs to be adjusted for phenocopy rates particularly in second-degree untested relatives

Overview of attention for article published in Breast Cancer Research, February 2013
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
9 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Contralateral breast cancer risk in BRCA1/2-positive families needs to be adjusted for phenocopy rates particularly in second-degree untested relatives
Published in
Breast Cancer Research, February 2013
DOI 10.1186/bcr3382
Pubmed ID
Authors

Evans DG, Howell A, Ingham SL, Buchan I, D Gareth R Evans, Anthony Howell, Sarah L Ingham, Iain Buchan

Abstract

In the previous issue of Breast Cancer Research, Rhiem and colleagues report contralateral breast cancer risks in relatives of BRCA1/2 mutation carriers as well as those testing negative. The authors quote 25-year risks of 44.1% for BRCA1 and 33.5% for BRCA2. The risks quoted are somewhat lower than might be inferred from previous estimates in BRCA1/2 carriers, which have been as high as 40% at 10 years . This discrepancy may be explained in part by the decision to exclude index cases in which there may have been testing bias to bilateral disease. However, the authors dismiss a second bias of including many non-carriers in their analysis as 'putative' carriers.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 11%
Japan 1 11%
Unknown 7 78%

Demographic breakdown

Readers by professional status Count As %
Professor 2 22%
Student > Doctoral Student 2 22%
Student > Ph. D. Student 2 22%
Other 1 11%
Lecturer 1 11%
Other 1 11%
Readers by discipline Count As %
Medicine and Dentistry 3 33%
Agricultural and Biological Sciences 2 22%
Social Sciences 2 22%
Biochemistry, Genetics and Molecular Biology 1 11%
Unspecified 1 11%
Other 0 0%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 February 2013.
All research outputs
#3,320,146
of 4,681,163 outputs
Outputs from Breast Cancer Research
#594
of 790 outputs
Outputs of similar age
#60,475
of 90,337 outputs
Outputs of similar age from Breast Cancer Research
#20
of 26 outputs
Altmetric has tracked 4,681,163 research outputs across all sources so far. This one is in the 16th percentile – i.e., 16% of other outputs scored the same or lower than it.
So far Altmetric has tracked 790 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one is in the 14th percentile – i.e., 14% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 90,337 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.